Precision Business Insights

Portfolio

Research Reports

SELECT LICENSE TYPE
Databank $ 3,000.00
spinner
Single User $ 4,400.00
spinner
Multiple User $ 6,600.00
spinner
Corporate User $ 8,900.00
spinner
buy now spinner

Why Precision Business Insights?

  • Pre and Post Sale Support

    Get in touch with our industry experts to resolve your research queries before and after buying the report. Avail free 60 minutes analyst tele-call to get additional market information before and after purchase

  • Special Pricing and Discounts

    Avail special pricing for the purchase of report sections,regional insights, and historical data. Discounts for government bodies, research institutes, universities, NGO’s and start-up’s

  • In-depth Market Analysis

    Our research reports provides holistic market information with 360 degree analysis. We adopt 3 pronged strategy to analyze the market i.e. Secondary research , primary research, and expert validation

  • Accurate and Reliable Market Data

    Utmost focus on delivering accurate and reliable research reports. We adopt internally developed data mining tools to eliminate any data errors

  • NICHE AND GROWTH MARKETS EXPERTISE

    Proven expertise in delivering new and emerging markets product and technology advancements. We provide market information across the developed and emerging markets

  • ADHERING TO QUICK DELIVERY TIME LINES

    We provide impeccable research reports in quick turnaround time

Asia Pacific Influenza Treatment Market – Market Estimation, Dynamics, Country Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024


 

Available formats:    

StumbleUponEmail

Asia Pacific Influenza Treatment Market

 

By Drug Class (Anti-Viral Drugs, Interferons, Vaccines), By Route of Administration (Oral, Parenteral, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others), and Geography – Market Estimation, Dynamics, Country Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Asia Pacific influenza treatment market was valued at US $ XX Mn and expected to grow at 2.2% Compound Annual Growth Rate (CAGR) from 2018 to 2024.

 

Market Outline: Asia Pacific Influenza Treatment Market

Influenza is an upper respiratory tract disease and is caused by the influenza virus. Influenza virus is mainly three types namely Influenza A, Influenza B, and Influenza C. Influenza is a communicable disease, spread through the flu cough, droplets from the infected people, sneeze or talks. The common symptoms occur in influenza patients are chills, cough, running nose, sore throat, body aches, headache, fatigue, some cases people may have vomiting and diarrhoea. The complication of the disease may include ear infections, bacterial pneumonia, dehydration, sinus infections, and sometimes it leads to congestive heart failure, and asthma.

 

Market Dynamics: Asia Pacific Influenza Treatment Market

Increase in the prevalence of influenza coupled with rise in geriatric population in Asia Pacific countries is a key factor drives the growth of Asia Pacific influenza treatment market over the forecast years. Moreover, increase in the R&D for the innovation of newer therapeutics for influenza treatment, government initiations to rise the awareness about influenza vaccine, frequent product launchings, and technological advancements in the disease diagnosis are anticipated to propel the Asia Pacific influenza treatment market over the forecast years. However, lack of required funding, limited opportunities for the production of vaccines, and stringent regulatory policies for new product approvals might hamper the growth of Asia Pacific influenza treatment market.

 

Market Scope: Asia Pacific Influenza Treatment Market

Asia Pacific influenza treatment market is segmented based on drug class, route of administration, and distribution channel

Based on drug class, market is segmented into the following:

  • Anti-viral drugs
  • Zanamivir
  • Oseltamivir
  • Amantadine
  • Rimantadine
  • Others
  • Interferons
  • Vaccines
  • Trivalent
  • Quadrivalent

Based on the route of administration, market is segmented into the following:

  • Oral
  • Anti-viral drugs
  • Parenteral
  • Interferon alfa-2b
  • Others

Based on the distribution channel, the market is segmented into the following:

  • Hospital pharmacies
  • Retail pharmacies
  • Others

 

Regional Analysis: Asia Pacific Influenza Treatment Market

Geographically, Asia Pacific influenza market is segmented into Japan, China, India, Australia & New Zealand, ASEAN Countries, South Korea, and Rest of Asia Pacific. Japan influenza treatment market is poised to grow due to rise in prevalence of influenza in Japan, frequent product approvals for the influenza drugs, and rise in awareness about the influenza vaccine are surge the market. China influenza treatment market has a lucrative growth attributed to high awareness about the vaccination among the people, innovation of newer therapeutics, and increase in healthcare expenditure are bolster the market. However, India influenza treatment market is driven by increase in the number of geriatric population, entry of market players into the country, and rise in incidence of the disease are fuel the market over the forecast years.

 

Competition Assessment: Asia Pacific Influenza Treatment Market

Some of the players in the Asia Pacific influenza market include:

  • AstraZeneca (U.K.)
  • Hoffmann-La Roche (Switzerland)
  • GlaxoSmithKline Plc. (U.K.)
  • Novartis AG (Switzerland)
  • Sanofi Pasture (France)
  • Protein Sciences Corporation (U.S.)
  • Emergent Biosolutions (U.S.)
  • BioCryst Pharmaceuticals.Inc. (U.S.)
  • Shionogi Inc. (Japan)
  • Abbott Laboratories Inc. (U.S.)

 

Notable Market Developments: Asia Pacific Influenza Treatment Market

  • In March 2018, Japanese pharma company Shionogi launched single-dose flu drug Xofluza (Baloxsvir marboxil) in Japan

 

  1. Executive Summary
  2. Asia Pacific Influenza Treatment Market Introduction
    • Asia Pacific Influenza Treatment Market – Taxonomy
    • Asia Pacific Influenza Treatment Market –Definitions
      • Drug Class
      • Route of Administration
      • Distribution Channel
  1. Asia Pacific Influenza Treatment Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Asia Pacific Influenza Treatment Market Dynamic Factors – Impact Analysis
    • Asia Pacific Influenza Treatment Market – Competition Landscape
    • Epidemiology
  2. Asia Pacific Influenza Treatment Market Analysis,2013 – 2017 and Forecast, 2018 – 2024
    • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market OpportunityAnalysis
  3. Asia Pacific Influenza Treatment Market, By Drug Class, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Anti-viral drugs
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Zanamivir
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Oseltamivir
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Amantadine
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Rimantadine
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Interferons
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Vaccines
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Trivalent
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Quadrivalent
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Asia Pacific Influenza Treatment Market Forecast, By Route of Administration,2013 – 2017 and Forecast, 2018 – 2024
    • Oral
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Anti-viral drugs
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Parenteral
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Interferon alfa-2b
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Asia Pacific Influenza Treatment Market Forecast, By Distribution Channel, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Hospital Pharmacies
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Retail Pharmacies
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Asia Pacific Influenza Treatment Market Forecast, By Country, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Japan
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • China
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • India
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Australia & New Zealand
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • ASEAN
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • South Korea
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Rest of Asia Pacific
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia Pacific Influenza Treatment Market – Opportunity Analysis Index, By Drug Class, By Route of Administration, By Distribution Channel and Country, 2018 – 2024
  2. Japan Influenza Treatment Market Analysis,2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Drug Class Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Anti-viral drugs
      • Zanamivir
      • Oseltamivir
      • Amantadine
      • Rimantadine
      • Others
      • Interferons
      • Vaccines
      • Trivalent
      • Quadrivalent
    • Route of Administration Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Anti-viral drugs
      • Parenteral
      • Interferon alfa-2b
      • Others
    • Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Others
    • Japan Influenza Treatment Market – Opportunity Analysis Index, By Drug Class, By Route of Administration and By Distribution Channel, 2018 – 2024
    • Japan Influenza Treatment Market Dynamics – Trends
  3. China Influenza Treatment Market Analysis,2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Drug Class Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Anti-viral drugs
      • Zanamivir
      • Oseltamivir
      • Amantadine
      • Rimantadine
      • Others
      • Interferons
      • Vaccines
      • Trivalent
      • Quadrivalent
    • Route of Administration Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Anti-viral drugs
      • Parenteral
      • Interferon alfa-2b
      • Others
    • Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Others
    • China Influenza Treatment Market – Opportunity Analysis Index, By Drug Class, By Route of Administration and By Distribution Channel, 2018 – 2024
    • China Influenza Treatment Market Dynamics – Trends
  4. India Influenza Treatment Market Analysis,2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Drug Class Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Anti-viral drugs
      • Zanamivir
      • Oseltamivir
      • Amantadine
      • Rimantadine
      • Others
      • Interferons
      • Vaccines
      • Trivalent
      • Quadrivalent
    • Route of Administration Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Anti-viral drugs
      • Parenteral
      • Interferon alfa-2b
      • Others
    • Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Others
    • India Influenza Treatment Market – Opportunity Analysis Index, By Drug Class, By Route of Administration and By Distribution Channel, 2018 – 2024
    • India Influenza Treatment Market Dynamics – Trends
  5. Australia & New Zealand Influenza Treatment Market Analysis,2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Drug Class Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Anti-viral drugs
      • Zanamivir
      • Oseltamivir
      • Amantadine
      • Rimantadine
      • Others
      • Interferons
      • Vaccines
      • Trivalent
      • Quadrivalent
    • Route of Administration Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Anti-viral drugs
      • Parenteral
      • Interferon alfa-2b
      • Others
    • Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Others
    • Australia & New Zealand Influenza Treatment Market – Opportunity Analysis Index, By Drug Class, By Route of Administration and By Distribution Channel, 2018 – 2024
    • Australia & New Zealand Influenza Treatment Market Dynamics – Trends
  6. ASEAN Influenza Treatment Market Analysis,2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Drug Class Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Anti-viral drugs
      • Zanamivir
      • Oseltamivir
      • Amantadine
      • Rimantadine
      • Others
      • Interferons
      • Vaccines
      • Trivalent
      • Quadrivalent
    • Route of Administration Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Anti-viral drugs
      • Parenteral
      • Interferon alfa-2b
      • Others
    • Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Others
    • ASEAN Influenza Treatment Market – Opportunity Analysis Index, By Drug Class, By Route of Administration and By Distribution Channel, 2018 – 2024
    • ASEAN Influenza Treatment Market Dynamics – Trends
  7. South Korea Influenza Treatment Market Analysis,2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Drug Class Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Anti-viral drugs
      • Zanamivir
      • Oseltamivir
      • Amantadine
      • Rimantadine
      • Others
      • Interferons
      • Vaccines
      • Trivalent
      • Quadrivalent
    • Route of Administration Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Anti-viral drugs
      • Parenteral
      • Interferon alfa-2b
      • Others
    • Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Others
    • South Korea Influenza Treatment Market – Opportunity Analysis Index, By Drug Class, By Route of Administration and By Distribution Channel, 2018 – 2024
    • South Korea Influenza Treatment Market Dynamics – Trends
  8. Rest of Asia Pacific Influenza Treatment Market Analysis,2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Drug Class Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Anti-viral drugs
      • Zanamivir
      • Oseltamivir
      • Amantadine
      • Rimantadine
      • Others
      • Interferons
      • Vaccines
      • Trivalent
      • Quadrivalent
    • Route of Administration Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Anti-viral drugs
      • Parenteral
      • Interferon alfa-2b
      • Others
    • Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Others
    • Rest of Asia Pacific Influenza Treatment Market – Opportunity Analysis Index, By Drug Class, By Route of Administration and By Distribution Channel, 2018 – 2024
    • Rest of Asia Pacific Influenza Treatment Market Dynamics – Trends
  9. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Drug Class& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • AstraZeneca (U.K.)
      • Hoffmann-La Roche (Switzerland)
      • GlaxoSmithKline Plc. (U.K.)
      • Novartis AG (Switzerland)
      • Sanofi Pasture (France)
      • Protein Sciences Corporation (U.S.)
      • Emergent Biosolutions (U.S.)
      • BioCryst Pharmaceuticals.Inc. (U.S.)
      • Shionogi Inc. (Japan)
      • Abbott Laboratories Inc. (U.S.)
  1. Research Methodology
  2. Key Assumptions and Acronyms

 

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

 

Avail Discount  Up To 20%

Need more discount on this report?

Call or e-mail us for:

(U.S.) – +1-866-598-1553

Contact SalesTOLL FREE: +1-866-598-1553